A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors.

ABSTRACT: Kinases are principal components of signal transduction pathways and the focus of intense basic and drug discovery research. Irreversible inhibitors that covalently modify non-catalytic cysteines in kinase active sites have emerged as valuable probes and approved drugs. Many protein classes, however, have functional cysteines, and therefore understanding the proteome-wide selectivity of covalent kinase inhibitors is imperative. Here, we accomplish this objective using activity-based protein profiling coupled with quantitative MS to globally map the targets, both specific and nonspecific, of covalent kinase inhibitors in human cells. Many of the specific off-targets represent nonkinase proteins that, notably, have conserved active site cysteines. We define windows of selectivity for covalen

SUBMITTER: Lanning BR 

PROVIDER: S-EPMC4138289 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature